Best-Selling (S)-(+)-3-Quinuclidinol - (S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Rivaroxaban Intermediate – Ruifu

Manufacturer Supply; High Purity and Competitive Price
Commercial Supply Rivaroxaban (CAS: 366789-02-8) Related Intermediates:
(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0
4-(4-Aminophenyl)morpholin-3-one CAS: 438056-69-0
2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione CAS: 446292-07-5
5-Chlorothiophene-2-carboxylic acid CAS: 24065-33-6
Rivaroxaban CAS: 366789-02-8

(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Synthesis Route

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-(+)-Glycidyl Phthalimide (CAS: 161596-47-0) with high quality. It is an intermediate typically in the synthesis of Rivaroxaban (CAS: 366789-02-8), in the treatment of Venous Thromboembolism (VTE). 

Rivaroxaban (Xarelto;   CAS: 366789-02-8) is an antithrombotic drug and was developed in a collaboration between the German Bayer Pharmaceuticals and American Johnson company. Rivaroxaban is indicated for the ‘treatment of deep vein thrombosis and pulmonary embolism, and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults.